The impact of maternal plasma volume expansion and antihypertensive treatment with intravenous dihydralazine on fetal and maternal hemodynamics during pre-eclampsia: A clinical, echo-Doppler and viscometric study

Ultrasound in Obstetrics and Gynecology

Volumn 23, Issue 4, 2004, Pages 327-332

  Boito, S M E ^a   Struijk, P C ^a   Pop, G A M ^a   Visser, W ^a   Steegers, E A P ^a   Wladimiroff, J W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Antihypertensive treatment; Maternal whole blood viscosity; Plasma volume expansion; Pre eclampsia; Umbilical artery pulsatility index; Umbilical venous volume flow; Uterine artery resistance index

Indexed keywords

DIHYDRALAZINE; PLASMA SUBSTITUTE;

ADULT; ARTERIAL BLOOD; ARTERIAL PRESSURE; ARTICLE; BLOOD VISCOSITY; BLOOD VOLUME; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOPPLER ECHOGRAPHY; DRUG EFFECT; FEMALE; FETUS; HEMATOCRIT; HEMODYNAMICS; HUMAN; MATERNAL CARE; MATERNAL HYPERTENSION; PARAMETER; PREECLAMPSIA; PRIORITY JOURNAL; PULSATILE FLOW; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; ULTRAVIOLET SPECTROPHOTOMETRY; UTERINE ARTERY; VISCOMETRY;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DIHYDRALAZINE; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; GESTATIONAL AGE; HEMATOCRIT; HUMANS; PLACENTAL CIRCULATION; PLASMA VOLUME; PRE-ECLAMPSIA; PREGNANCY; PULSATILE FLOW; UMBILICAL ARTERIES; UMBILICAL VEINS; VASCULAR RESISTANCE; VISCOSITY;

EID: 1942532073     PISSN: 09607692     EISSN: None     Source Type: Journal    
DOI: 10.1002/uog.1012     Document Type: Article

References (40)

1. Visser W, Wallenburg HC. Central hemodynamic observations in untreated preeclamptic patients. Hypertension 1991; 17: 1072-1077.
2. Silver HM, Seebeck M, Carlson R. Comparison of total blood volume in normal, preeclamptic, and nonproteinuric gestational hypertensive pregnancy by simultaneous measurement of red blood cell and plasma volumes. Am J Obstet Gynecol 1998; 179: 87-93.
3. Heilmann L. Rheologie et hypertension gravidique [Rheology and gravidic hypertension]. Rev Fr Gynecol Obstet 1991; 86: 164-167.
4. Pribush A, Mankuta D, Meiselman HJ, Meyerstein D, Silberstein T, Katz M, Meyerstein N. The effect of low-molecular weight dextran on erythrocyte aggregation in normal and preeclamptic pregnancy. Clin Hemorheol Microcirc 2000; 22: 143-152.
5. Van Hook JW. Management of complicated preeclampsia. Semin Perinatol 1999; 23: 79-90.
6. Visser W, Wallenburg HC. Maternal and perinatal outcome of temporizing management in 254 consecutive patients with severe pre-eclampsia remote from term. Eur J Obstet Gynecol Reprod Biol 1995; 63: 147-154.
7. Visser W, Wallenburg HC. Temporising management of severe pre-eclampsia with and without the HELLP syndrome. Br J Obstet Gynaecol 1995; 102: 111-117.
8. Snijders R, Nicolaides KH. Fetal biometry at 14-40 weeks' gestation. Ultrasound Obstet Gynecol 1994; 4: 34-38.
9. Stewart PA, Wladimiroff JW, Stijnen T. Blood flow velocity waveforms from the fetal external iliac artery as a measure of lower extremity vascular resistance. Br J Obstet Gynaecol 1990; 97: 425-430.
10. Boito S, Struijk PC, Ursem NT, Stijnen T, Wladimiroff JW. Umbilical venous volume flow in the normally developing and growth-restricted human fetus. Ultrasound Obstet Gynecol 2002; 19: 344-349.
11. Campbell S, Diaz-Recasens J, Griffin DR, Cohen-Overbeek TE, Pearce JM, Willson K, Teague MJ. New Doppler technique for assessing uteroplacental blood flow. Lancet 1983; 1: 675-677.
12. Harrington K, Cooper D, Lees C, Hecher K, Campbell S. Doppler ultrasound of the uterine arteries: the importance of bilateral notching in the prediction of pre-eclampsia, placental abruption or delivery of a small-for-gestational-age baby. Ultrasound Obstet Gynecol 1996; 7: 182-188.
13. Kloosterman G. On intrauterine growth. Int J Gynaecol Obstet 1970; 8: 895-912.
14. Wallenburg H. Hemodynamics in hypertensive pregnancy. In Handbook of Hypertension, vol. 21, Rubin P (ed.). Elsevier Science Publishers: Amsterdam, 2000; 181-220.
15. Khedun SM, Moodley J, Naicker T, Maharaj B. Drug management of hypertensive disorders of pregnancy. Pharmacol Ther 1997; 74: 221-258.
16. Sehgal NN, Hitt JR. Plasma volume expansion in the treatment of pre-eclampsia. Am J Obstet Gynecol 1980; 138: 165-168.
17. Gallery ED, Delprado W, Gyory AZ. Antihypertensive effect of plasma volume expansion in pregnancy-associated hypertension. Aust N Z J Med 1981; 11: 20-24.
18. Gallery ED, Mitchell MD, Redman CW. Fall in blood pressure in response to volume expansion in pregnancy-associated hypertension (pre-eclampsia): why does it occur? J Hypertens 1984; 2: 177-182.
19. Allen DG, Davey DA, Dacre D. Plasma volume expansion in pregnancy hypertension. S Afr Med J 1988; 73: 518-521.
20. Belfort M, Uys P, Dommisse J, Davey DA. Haemodynamic changes in gestational proteinuric hypertension: the effects of rapid volume expansion and vasodilator therapy. Br J Obstet Gynaecol 1989; 96: 634-641.
21. Buchan PC. Maternal and fetal blood viscosity throughout normal pregnancy. J Obstet Gynecol 1984; 4: 143-150.
22. Bolte AC, van Geijn HP, Dekker GA. Management and monitoring of severe preeclampsia. Eur J Obstet Gynecol Reprod Biol 2001; 96: 8-20.
23. de Jong CL, Dekker GA, Sibai BM. The renin-angiotensin-aldosterone system in preeclampsia. A review. Clin Perinatol 1991; 18: 683-711.
24. Phyllis A. Hemodynamics in hypertensive pregnancy. In Handbook of Hypertension, vol. 21, Rubin P (ed.). Elsevier Science Publishers: Amsterdam, 2000; 57-75.
25. Belfort M, Akovic K, Anthony J, Saade G, Kirshon B, Moise K Jr. The effect of acute volume expansion and vasodilatation with verapamil on uterine and umbilical artery Doppler indices in severe preeclampsia. J Clin Ultrasound 1994; 22: 317-325.
26. Gosling P, Lo PTS, Taylor M. Interpretation of pulsatility index in feeder arteries to low-impedance vascular beds. Ultrasound Obstet Gynecol 1991; 1: 175-179.
27. Grunewald C, Kublickas M, Nisell H, Nylund H, Westgren M. The interpretation of uterine artery pulsatility index in normal and hypertensive pregnancy. Ultrasound Obstet Gynecol 1994; 4: 476-479.
28. Jouppila P, Kirkinen P, Puukka R. Correlation between umbilical vein blood flow and umbilical blood viscosity in normal and complicated pregnancies. Arch Gynecol 1986; 237: 191-197.
29. Tenenbaum DG, Piasecki GJ, Oh W, Rosenkrantz TS, Jackson BT. Fetal polycythemia and hyperviscosity: effect on umbilical blood flow and fetal oxygen consumption. Am J Obstet Gynecol 1983; 147: 48-51.
30. Buchan PC. Preeclampsia - a hyperviscosity syndrome. Am J Obstet Gynecol 1982; 142: 111-112.
31. Karsdorp VH, van Vugt JM, Dekker GA, van Geijn HP. Reappearance of end-diastolic velocities in the umbilical artery following maternal volume expansion: a preliminary study. Obstet Gynecol 1992; 80: 679-683.
32. Linderkamp O. Placental transfusion: determinants and effects. Clin Perinatol 1982; 9: 559-592.
33. Schrock R, Heimisch W, Gebhardt K, Mendler N. Hemodilution as a therapeutic procedure in EPH gestosis. Bibl Haematol 1981; 47: 86-96.
34. Siekmann U, Heilmann L, Klosa W, Quaas L, Schillinger H. Simultaneous investigations of maternal cardiac output and fetal blood flow during hypervolemic hemodilution in preeclampsia - preliminary observations. J Perinat Med 1986; 14: 59-69.
35. Greiss FC Jr. Pressure-flow relationship in the gravid uterine vascular bed. Am J Obstet Gynecol 1966; 96: 41-47.
36. Erkkola R, Tabsh K, Ushioda E, Nuwayhid B, Brinkman CR 3rd, Assali NS. Responses of the pelvic vascular bed to intra-arterial stimulation of beta-adrenergic and cholinergic receptors in pregnant and nonpregnant sheep. Am J Obstet Gynecol 1981; 141: 599-607.
37. Nelson SH, Steinsland OS, Wang Y, Yallampalli C, Dong YL, Sanchez JM. Increased nitric oxide synthase activity and expression in the human uterine artery during pregnancy. Circ Res 2000; 87: 406-411.
38. Liedholm H, Wahlin-Boll E, Hanson A, Ingemarsson I, Melander A. Transplacental passage and breast milk concentrations of hydralazine. Eur J Clin Pharmacol 1982; 21: 417-419.
39. Jouppila P, Kirkinen P, Koivula A, Ylikorkala O. Effects of dihydralazine infusion on the fetoplacental blood flow and maternal prostanoids. Obstet Gynecol 1985; 65: 115-118.
40. Heyl W, Boabang P, Faridi A, Rath W. Evaluation of the success of hemodilution therapy for fetal growth retardation by Doppler sonography. Clin Hemorheol Microcirc 1997; 17: 225-230.